vancouver coastal health
-
Eleven remarkable individuals will receive honorary degrees this year from the University of British Columbia.
-
B.C. researchers launching clinical trial for first genetically engineered stem cell-based therapy for type 1 diabetes
Researchers from the University of British Columbia and Vancouver Coastal Health (VCH) have received $1 million from Canada’s Stem Cell Network to conduct research and a clinical trial for one of the world’s first genetically engineered cell replacement therapies for type 1 diabetes.
-
Stem cell-based treatment produces insulin in patients with Type 1 diabetes
In the first study of its kind, a team of researchers at the University of British Columbia’s faculty of medicine and Vancouver Coastal Health (VCH) has helped to demonstrate that a stem cell-based treatment delivered through an implantable device can produce insulin in the human body.
-
Researchers launch study into COVID-19 vaccine uptake and efficacy in vulnerable urban populations
In this Q&A, Dr. Brittany Barker, postdoctoral fellow with UBC’s department of medicine and research scientist at BCCSU, and Dr. Hudson Reddon, postdoctoral research fellow with UBC’s department of medicine, discuss how COVID-19 and vaccinations are being experienced by vulnerable populations.
-
Uncontrolled asthma could cost U.S. economy more than $963 billion in the next 20 years
The medical costs of uncontrolled asthma, combined with productivity losses due to sick days, could cost the U.S. economy more than $963 billion over the next 20 years, finds a new study led by researchers at the University of British Columbia.
-
Potential new diabetes treatment being tested in Vancouver
The University of British Columbia and Vancouver Coastal Health are testing a possible diabetes cure that replaces a person’s damaged pancreatic cells with new ones grown in the lab.
